Tolosa 
Introduction
Tolosa-Hunt syndrome (THS) is a rare disorder indicated by recurrent painful opthalmoplegia caused by non-specific inflammation of the cavernous sinus or superior orbital fissure (SOF). The disease shares histopathological features with idiopathic orbital pseudotumour; however, owning to its anatomical location, it produces characteristics clinical manifestation. 1 Recurrent retro-orbital pain, with palsies of the third, fourth or sixth cranial nerves as well as the first and second divisions of the trigeminal nerve, are typical. Clinically, immediate response to steroid therapy is a hallmark of the condition.
The clinical presentation of THS has a wide differential diagnosis, and timely and appropriate imaging -as an adjunct to pertinent laboratory investigations -can greatly assist clinicians with early accurate diagnosis and management.
Case Report
A 40-year old lady presented with a severe right sided headache, was throbbing nature and associated with vomiting for 4 times. Headache was persistent and progressively increasing for twelve hours. Headache was not associated with any aura, convulsion or unconsciousness. On the next day she developed dropping of the right eyelid. The patient was afebrile and there was no weakness of any limb or altered sensation. There is also no history of head trauma and her bowel bladder habit was normal.
On clinical examination her pulse was76 bit per minute (regular); BP 120/85mm of Hg. She had complete ptosis on right side, pupil was dilated and both direct and consensual light reflex was absent. There was complete ophthalmoplegia on right side. Her pain and touch sensation was impaired along the distribution of ophthalmic division of trigeminal nerve. Fundoscopy was normal.
Her investigation showed: WBC 12 X 10 9 /L, 85% neutrophil, ESR 60mm in first hour, total cholesterol was 369mg/dl,ANA negative, CSF leucocytes 40/cmm, lymphocyte 95%.CT scan of brain showed small lacunar infarct in the right side centrum semi ovale. MRI of brain asymmetrical widening of right parasellar region.
Fig. 1: MRI of Brain asymmetrical widening of right parasellar region

Discussion
Tolosa first described the condition in 1954, in a patient with unilateral recurrent painful opthalmoplegia involving cranial nerves III, IV, VI and V 1 . The patient was imaged using carotid angiography and segmental narrowing of the carotid siphon was seen. 1 Hunt et al. described 6 patients with similar clinical finding in 1961, and proposed a lowgrade non-specific inflammation of the cavernous sinus and its walls as the cause of the syndrome. Pathologically infiltration of lymphocytes and plasma cells as well as thickening of the dura mater was seen. 1 The condition was termed Tolosa-Hunt syndrome by Smith and Taxal in 1966. 2 The latter authors stressed the importance ofthe dramatic rapid response to steroid therapy.
In 1988, THS criteria were provided by the International Headache Society (IHS), and further revised in 2004 (Table I) . 3, 4 Our patient fulfilled all the criteria provided by IHS. She presented within 12 hours of pain onset and she had paresis of IV, V, VI cranial nerves as well as first division of the trigeminal nerve. Her pain resolved within 48 hours of steroid therapy and other differential diagnosis was excluded by imaging of the brain. The patient was treated with oral steroids and showed significant relief of symptoms over following 48 hours. During discharge after 7 days her ptosis was not completely resolved but complete resolution of ptosis as well as oculomotor nerve palsy was found during followup after one month. Neuroimaging -in particular MRI -is an essential part of the workup of any patient presenting with features of THS, as these features are non-specific and have a wide differential diagnosis, including meningioma, sarcoidosis, pituitary tumours, tuberculous meningitis (TBM) and lymphoma, Wegener granulomatosis, ophthalmoplegic migraine. 2 MRI findings classically demonstrate a softtissue mass lesion involving the SOF or cavernous sinus. Signal characteristics are typically hypointense to fat and isointense to muscle on short TR/TE sequences and isointense to fat on long TR/TE sequences. 5 Significant enhancement of the mass lesion is demonstrated on CE sequences. Of the particular value is the post-contract fatsaturated thin-slice coronal images through the orbital apex and cavernous sinus.
Administration of systemic steroid for 48 hours in a patient with THS produces a dramatic response in painful ophthalmoplegia that allows differentiation of this cause from other conditions of painful ophthalmoplegia. 6 Even though there is no standardize dose specified in the literature, this type of the treatment with steroid at a dose of 1mg/kg/day tapered slowly over three to four months has been well received. 3 
Conclusion
TSH is rare disorder, and diagnosis of exclusion. Steroid treatment if the cornerstone in the management of THS. In the presence of painful opthalomoplegia, the finding by MRI of cavernous sinus englargement and rapid resolution of the clinical symptoms with steroid therapy are characteristics.
